HCC tissues; adjacent liver specimens; adjacent non-tumorous tissues; para-cancerous tissues
MHCC-97H; SMMC-7721; Hep3B; Huh7; HepG2; SK-HEP-1; HL-7702
cell line-derived xenograft
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); cell cycle (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; RT-qPCR; RNA-seq; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RNA Pull-Down; Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Colony Formation Assay; Cell Cycle Assay; Transwell Assay; Wound Healing Assay; In Vivo Animal Model; Western Blot; Cohort Study; Survival Analysis; Bioinformatics Analysis
High circ_0005218 expression is associated with tumor number, microvascular invasion, tumor early recurrence, poor OS and DFS, and may serve as a biomarker for HCC early recurrence prediction and a therapeutic target.
hsa_circ_0005218/circ_0005218 is up-regulated in HCC, especially early recurrent HCC tissues, and high expression predicts poor OS and DFS. Functionally, it promotes HCC proliferation, migration, invasion, metastasis, cell cycle progression and xenograft growth. Mechanistically, it sponges miR-31-5p to relieve suppression of CDK1, supporting a circ_0005218/miR-31-5p/CDK1 regulatory axis and potential use as an early recurrence biomarker and therapeutic target.
0.8793
Circular RNA hsa_circ_0005218 promotes the early recurrence of hepatocellular carcinoma by targeting the miR-31-5p/CDK1 pathway.
combined biological and clinical study